Oscar Health, Inc. OSCR
We take great care to ensure that the data presented and summarized in this overview for Oscar Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OSCR
View all-
Vanguard Group Inc Valley Forge, PA18.4MShares$332 Million0.01% of portfolio
-
Black Rock Inc. New York, NY14.2MShares$255 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD11.7MShares$210 Million0.15% of portfolio
-
Dragoneer Investment Group, LLC San Francisco, CA9.49MShares$171 Million4.25% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY7.85MShares$141 Million3.1% of portfolio
-
Viking Global Investors LP6.17MShares$111 Million0.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$97 Million0.01% of portfolio
-
State Street Corp Boston, MA5.13MShares$92.4 Million0.0% of portfolio
-
Thrive Capital Management, LLC New York, NY4.76MShares$85.6 Million10.05% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.47MShares$80.5 Million0.02% of portfolio
Latest Institutional Activity in OSCR
Top Purchases
Top Sells
About OSCR
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Insider Transactions at OSCR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 14
2024
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
344,522
+2.76%
|
$5,167,830
$15.79 P/Share
|
Nov 14
2024
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
344,522
+2.76%
|
$5,167,830
$15.79 P/Share
|
Nov 13
2024
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
358,619
+5.81%
|
$4,662,047
$13.74 P/Share
|
Nov 13
2024
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
358,619
+5.81%
|
$4,662,047
$13.74 P/Share
|
Nov 12
2024
|
Jeffery H Boyd |
BUY
Exercise of conversion of derivative security
|
Direct |
577,027
+45.49%
|
$2,308,108
$4.29 P/Share
|
Nov 12
2024
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
420,819
+7.17%
|
$5,470,647
$13.68 P/Share
|
Nov 12
2024
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
420,819
+7.17%
|
$5,470,647
$13.68 P/Share
|
Nov 11
2024
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
276,040
+5.2%
|
$3,588,520
$13.58 P/Share
|
Nov 11
2024
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
276,040
+5.2%
|
$3,588,520
$13.58 P/Share
|
Sep 06
2024
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
29,957
-3.39%
|
$509,269
$17.06 P/Share
|
Sep 06
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
16,793
-4.1%
|
$285,481
$17.06 P/Share
|
Sep 05
2024
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+6.6%
|
-
|
Sep 05
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+7.09%
|
-
|
Sep 04
2024
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
62,881
-3.62%
|
$1,068,977
$17.66 P/Share
|
Sep 04
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
70,356
-8.18%
|
$1,196,052
$17.66 P/Share
|
Sep 04
2024
|
Steven Wolin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,337
-5.15%
|
$158,729
$17.66 P/Share
|
Sep 04
2024
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
32,978
-6.77%
|
$560,626
$17.66 P/Share
|
Sep 04
2024
|
Mario Schlosser President of Technology & CTO |
SELL
Open market or private sale
|
Direct |
2,916
-1.91%
|
$49,572
$17.66 P/Share
|
Sep 04
2024
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,852
-1.38%
|
$65,484
$17.66 P/Share
|
Sep 03
2024
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
68,978
-7.24%
|
$1,172,626
$17.99 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 3.17M shares |
---|---|
Grant, award, or other acquisition | 129K shares |
Open market or private purchase | 2.8M shares |
Open market or private sale | 899K shares |
---|